Successful translation and future prospects of TALEN editing for leukemia patients

Expert Opin Biol Ther. 2018 Jul;18(7):725-726. doi: 10.1080/14712598.2018.1484105. Epub 2018 Jun 14.

Authors

Mariana Werner Sunderland^{1

2}, Karl S Peggs^{1

2}

Affiliations

¹ a Cancer Immunology Unit , University College London Cancer Institute , London , UK.
² b Research Department of Haematology , UCL Cancer Institute , London , UK.

PMID: 29860877
DOI: 10.1080/14712598.2018.1484105

No abstract available

Keywords: Adoptive cell therapy; CRISPR; TALEN; gene editing; immunotherapy; leukemia; universal CAR T cell.

Publication types

Editorial